Previous studies have shown a potential link between GLP-1 use and non-arteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause vision loss
You can always read more in our main ergothioneine , MitoPrime , and MITOgreens articles, or see the supplements listed above
In our November review, Nutrition Insight highlights some of the months biggest stories, including breakthrough GLP-1 research and drug development, our discussion with AAK on the impact of supply chains on nutrition innovation, and Novonesis latest insights into microbiome-focused healthy longevity innovations
We encourage you to schedule a consultation to discuss these options and determine whether peptide therapy might be a beneficial addition to your personalized pain management plan
Most clinical trial data spans 1268 weeks, leaving questions about multi-year safety profiles unanswered
At 3 months post-index, there was a substantial decrease in 0.25-mg s.c